BeStock  

硕腾 ZTS

美股市值排名 #630药品制造-专科与仿制
$79.40 −$2.71 (-3.30%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $79.45 +0.06%
开盘$79.00
昨收$82.11
当日区间$78.63 – $80.67
成交量6.02M
市值$32.26B
市盈率(TTM)13.4
股息率2.63%

基本面

最新报告季度:Q2, ended Jun 2026

营收$2.47B-0.2% YoY
营业利润$999.00M+0.2% YoY
净利润$691.00M-4.8% YoY
摊薄每股收益$1.65+1.2% YoY
自由现金流$538.00M+17.2% YoY
经营现金流$655.00M

营收,近8个季度

$2.4BSep '24$2.3BDec '24$2.2BMar '25$2.5BJun '25$2.4BSep '25$2.4BDec '25$2.3BMar '26$2.5BJun '26

净利润,近8个季度

$692.0MSep '24$581.0MDec '24$602.0MMar '25$726.0MJun '25$721.0MSep '25$603.0MDec '25$601.0MMar '26$691.0MJun '26

各季度摊薄每股收益

1.50Sep '241.29Dec '241.34Mar '251.63Jun '251.63Sep '251.37Dec '251.42Mar '261.65Jun '26

各季度自由现金流

$784.0MSep '24$689.0MDec '24$337.0MMar '25$459.0MJun '25$755.0MSep '25$732.0MDec '25$291.0MMar '26$538.0MJun '26

年度营收

$6.7BFY20$7.8BFY21$8.1BFY22$8.5BFY23$9.3BFY24$9.5BFY25

盈利能力与资产负债表

毛利率71.7%
营业利润率37.9%
净利率27.7%
净资产收益率64.9%
资产收益率17.8%
投入资本回报率24.2%
流动比率3.08
负债/资产比率79.1%
现金及投资$1.67B
总负债$9.24B
净现金(净负债)-$7.57B
自由现金流/营收24.3%

营收构成

2026/Q2 季度

按业务线

  • Parasiticides$698.00M 28.3%
  • Vaccines$521.00M 21.1%
  • Dermatology$398.00M 16.1%
  • Anti-infectives$244.00M 9.9%
  • Pain and sedation$217.00M 8.8%
  • Other pharmaceuticals$168.00M 6.8%
  • Animal health diagnostics$123.00M 5.0%
  • Other non-pharmaceuticals$70.00M 2.8%
  • Contract manufacturing & human health$29.00M 1.2%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $2.47B $2.26B $9.47B $2.39B $2.40B
营业总收入 $2.47B $2.26B $9.47B $2.39B $2.40B
营业成本 $673.00M $641.00M $2.67B $712.00M $683.00M
毛利润 $1.80B $1.62B $6.80B $1.68B $1.72B
营业费用 $796.00M $799.00M $3.20B $849.00M $781.00M
销售及管理费用 $592.00M $588.00M $2.38B $619.00M $579.00M
研发费用 $173.00M $180.00M $698.00M $199.00M $170.00M
折旧、摊销与折耗 $31.00M $31.00M $128.00M $31.00M $32.00M
-折旧与摊销 $31.00M $31.00M $128.00M $31.00M $32.00M
营业利润 $999.00M $822.00M $3.60B $826.00M $936.00M
非经营性利息净收入(支出) -$45.00M -$41.00M -$129.00M -$32.00M -$32.00M
非经营性利息收入 $16.00M $21.00M $93.00M $25.00M $26.00M
非经营性利息支出 $61.00M $62.00M $222.00M $57.00M $58.00M
其他收入(支出) -$88.00M -$23.00M -$108.00M -$33.00M -$17.00M
证券出售收益 -$10.00M -$6.00M -$45.00M -$10.00M -$13.00M
特殊收益(费用) -$76.00M -$16.00M -$59.00M -$17.00M -$4.00M
-减:重组及并购费用 $77.00M $22.00M $29.00M $17.00M $4.00M
-减:资本性资产减值 $0.00 – $5.00M $0.00 $0.00
-减:核销 $0.00 – $22.00M $0.00 $0.00
-业务出售收益 $0.00 – -$3.00M $0.00 $0.00
-固定资产出售收益 $1.00M $6.00M $0.00 $0.00 $0.00
其他非经营性收入(支出) -$2.00M -$1.00M -$4.00M -$6.00M –
税前利润 $866.00M $758.00M $3.36B $761.00M $887.00M
税费 $175.00M $157.00M $687.00M $158.00M $166.00M
净利润 $691.00M $601.00M $2.67B $603.00M $721.00M
持续经营利润 $691.00M $601.00M $2.67B $603.00M $721.00M
少数股东权益 $0.00 $0.00 $0.00 $0.00 $0.00
归属母公司净利润 $691.00M $601.00M $2.67B $603.00M $721.00M
归属普通股股东净利润 $691.00M $601.00M $2.67B $603.00M $721.00M
基本每股收益 $1.65 $1.42 $6.03 $1.38 $1.63
摊薄每股收益 $1.65 $1.42 $6.02 $1.37 $1.63
每股股息 $0.53 $0.53 $2.00 $0.50 $0.50

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $15.08B $15.15B $15.47B $15.47B $15.16B
流动资产合计 $6.36B $6.47B $6.77B $6.77B $6.58B
现金及现金等价物与短期投资 $1.67B $1.94B $2.31B $2.31B $2.08B
-现金及现金等价物 $1.47B $1.94B $2.31B $2.31B $2.08B
-短期投资 $200.00M – – – –
应收款 $1.57B $1.51B $1.59B $1.59B $1.54B
-应收账款 $1.57B $1.51B $1.59B $1.59B $1.54B
存货 $2.57B $2.55B $2.43B $2.43B $2.47B
受限现金 $3.00M $1.00M $2.00M $2.00M $4.00M
其他流动资产 $535.00M $477.00M $436.00M $436.00M $493.00M
非流动资产合计 $8.72B $8.68B $8.70B $8.70B $8.58B
固定资产净值 $4.03B $4.00B $3.97B $3.97B $3.89B
-固定资产原值 $4.03B $4.00B $6.89B $6.89B $6.76B
商誉及其他无形资产 $3.69B $3.74B $3.77B $3.77B $3.80B
-商誉 $2.77B $2.78B $2.77B $2.77B $2.76B
-其他无形资产 $918.00M $959.00M $998.00M $998.00M $1.04B
一年以上递延资产 $617.00M $591.00M $637.00M $637.00M $587.00M
其他非流动资产 $384.00M $351.00M $328.00M $328.00M $293.00M
负债合计 $11.93B $11.92B $12.14B $12.14B $9.76B
流动负债合计 $2.06B $2.05B $2.24B $2.24B $1.81B
应付款 $811.00M $942.00M $866.00M $866.00M $562.00M
-应付账款 $452.00M $507.00M $487.00M $487.00M $410.00M
-应付税款合计 $138.00M $211.00M $147.00M $147.00M $152.00M
-应付股利 $221.00M $224.00M $232.00M $232.00M $0.00
一年内应计费用 $856.00M $751.00M $852.00M $852.00M $809.00M
其他流动负债 $125.00M $121.00M $107.00M $107.00M $99.00M
非流动负债合计 $9.87B $9.87B $9.90B $9.90B $7.95B
长期应付账款及其他应付款 $288.00M $281.00M $276.00M $276.00M $270.00M
长期债务及融资租赁负债 $9.24B $9.24B $9.24B $9.24B $7.27B
-长期债务 $9.05B $9.05B $9.04B $9.04B $7.07B
-长期融资租赁负债 $190.00M $193.00M $196.00M $196.00M $204.00M
一年以上递延负债 $122.00M $130.00M $139.00M $139.00M $147.00M
其他非流动负债 $220.00M $219.00M $248.00M $248.00M $264.00M
股东权益合计 $3.15B $3.23B $3.33B $3.33B $5.40B
股东权益 $3.15B $3.23B $3.33B $3.33B $5.40B
股本 $5.00M $5.00M $5.00M $5.00M $5.00M
-普通股 $5.00M $5.00M $5.00M $5.00M $5.00M
资本公积 $1.13B $1.11B $1.10B $1.10B $1.22B
留存收益 $14.65B $14.18B $13.74B $13.74B $13.59B
减:库存股 $11.85B $11.29B $10.69B $10.69B $8.61B
不影响留存收益的损益 -$796.00M -$772.00M -$834.00M -$834.00M -$818.00M
少数股东权益 $0.00 $0.00 $0.00 $0.00 $0.00
-累计折旧 – – -$2.93B -$2.93B -$2.87B

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $655.00M $401.00M $2.90B $893.00M $891.00M
持续经营经营活动现金流净额 $655.00M $401.00M $2.90B $893.00M $891.00M
持续经营净利润 $691.00M $601.00M $2.67B $603.00M $742.00M
持续经营损益 $2.00M -$9.00M $14.00M $0.00 $11.00M
折旧、折耗与摊销 $119.00M $119.00M $487.00M $121.00M $123.00M
递延税款 -$33.00M $34.00M -$52.00M -$48.00M -$16.00M
其他非现金项目 -$5.00M $3.00M -$8.00M $1.00M -$7.00M
营运资金变动 -$158.00M -$385.00M -$408.00M $170.00M -$7.00M
-应收款变动 -$66.00M -$106.00M -$236.00M -$52.00M -$32.00M
-存货变动 -$23.00M -$114.00M -$199.00M $13.00M -$45.00M
-应付账款及应计费用变动 -$53.00M $62.00M $46.00M $76.00M -$45.00M
-其他流动资产变动 -$92.00M -$66.00M -$165.00M $10.00M $6.00M
-其他流动负债变动 $142.00M -$234.00M $85.00M $88.00M $58.00M
-其他营运资金变动 -$66.00M $73.00M $61.00M $35.00M $51.00M
投资活动现金流净额 -$300.00M -$87.00M -$748.00M -$166.00M -$167.00M
持续经营投资活动现金流净额 -$300.00M -$87.00M -$748.00M -$166.00M -$167.00M
资本支出 -$117.00M -$110.00M -$621.00M -$161.00M -$136.00M
投资购置及出售净额 -$186.00M $14.00M -$100.00M $11.00M -$32.00M
其他投资变动净额 $3.00M $9.00M $1.00M -$2.00M $1.00M
筹资活动现金流 -$813.00M -$840.00M -$1.87B -$495.00M -$134.00M
持续经营筹资活动现金流净额 -$813.00M -$840.00M -$1.87B -$495.00M -$134.00M
普通股发行净额 -$584.00M -$606.00M -$3.24B -$2.06B -$394.00M
已付现金股利 -$223.00M -$224.00M -$889.00M -$220.00M -$222.00M
股票期权行使所得 -$5.00M -$7.00M -$11.00M – –
其他筹资费用净额 -$1.00M -$3.00M -$233.00M -$204.00M -$28.00M
期末现金余额 $1.48B $1.94B $2.31B $2.31B $2.08B
现金净变动 -$458.00M -$526.00M $286.00M $232.00M $590.00M
期初现金余额 $1.94B $2.45B $1.99B $2.08B $1.63B
汇率变动影响 -$7.00M $17.00M $39.00M -$4.00M -$11.00M
自由现金流 $538.00M $291.00M $2.28B $732.00M $755.00M
业务购买及出售净额 – – -$28.00M -$14.00M $0.00
债务发行及偿还净额 – – $2.50B $2.00B –

讨论区

暂无评论——快来第一个聊聊 ZTS。

登录后参与讨论。

Scroll to Top